403 results on '"Giaj-Levra, N."'
Search Results
2. Hypofractionated Postoperative Radiotherapy in Prostate Cancer with Ialuril Soft Gels®: Toxicity and Efficacy Analysis on a Retrospective Series of 305 Patients
3. A multi-institutional analysis of fractionated versus single-fraction stereotactic body radiotherapy (SBRT) in the treatment of primary lung tumors: a comparison between two antipodal fractionations
4. Long-term disease outcome and volume-based decision strategy in a large cohort of multiple brain metastases treated with a mono-isocentric linac-based Stereotactic Radiosurgery technique
5. P1.28-09 Definition of Resectable Stage III Non-small Cell Lung Cancer (NSCLC): A Clinical Case Review by a Pan-European Expert Panel
6. P1.28-08 Definition of Resectable Stage III Non-Small Cell Lung Cancer: A Systematic Review from EORTC Lung Cancer Group
7. 1.5T MR-Guided Daily Adaptive Radiotherapy: Preliminary Clinical Report of the First 5000 Fractions
8. PO-1485 1.5T MR-guided daily adaptive radiotherapy: preliminary clinical report of the first 5000 fractions
9. PO-1601 Stereotactic body radiotherapy (SBRT) with or without dose boost in spinal oligometastatic patients
10. PD-0071 SBRT for spine oligometastases: a multicenter retrospective study on behalf of AIRO
11. PO-1486 Feasibility and tolerability of MR-guided adaptive RT on prostatic bed:mono-institutional experience
12. Toxicity patterns and preliminary clinical outcomes of 1.5T MR-guided stereotactic body radiotherapy for prostate cancer
13. 1.5T MR-guided daily-adapted stereotactic body radiotherapy for prostate re-irradiation: A preliminary report of toxicity and clinical outcomes
14. Fentanyl pectin nasal spray for painful mucositis in head and neck cancers during intensity-modulated radiation therapy with or without chemotherapy
15. Radiation dose intensification in pre-operative chemo-radiotherapy for locally advanced rectal cancer
16. 1828P A cross-sectional study investigating the current diagnostic & therapeutical approaches to bone metastases (BoM) in patients (pts) with non-small cell lung cancer (NSCLC)
17. Stereotactic body radiation therapy and intensity modulated radiation therapy induce different plasmatic cytokine changes in non-small cell lung cancer patients: a pilot study
18. Cachexia induces head and neck changes in locally advanced oropharyngeal carcinoma during definitive cisplatin and image-guided volumetric-modulated arc radiation therapy
19. The impact of prostate gland dimension in genitourinary toxicity after definitive prostate cancer treatment with moderate hypofractionation and volumetric modulated arc radiation therapy
20. Stereotactic ablative body radiotherapy of ventricular tachycardia. Single italian centre experience
21. PD-0250 Therapeutic use of Linac-based SRS in malignant spasticity: early results from a prospective trial
22. PO-1452 Stereotactic ablative radiotherapy in patients with refractory ventricular tachyarrhythmia
23. PO-1407 Postoperative hypofractionated RT: toxicity and efficacy in a series of 304 prostate adenocarcinoma
24. PD-0086 PSMA-PET guided stereotactic body radiotherapy for bone oligorecurrent prostate cancer
25. PO-1463 SBRT for over 80years oligometastatic patients: report of feasibility and clinical outcomes
26. PO-1773 Feasibility of a novel harmonization method for NSCLC multi-centric radiomic studies
27. PO-1353 SBRT for gynecological oligometastases: mono-institutional report of toxicity and clinical outcomes
28. PO-1188 Stereotactic body RT (SBRT) and concomitant systemic therapy in oligoprogressive breast cancer
29. PD-0574 1.5T MR-guided RT versus linac-based VMAT SBRT in localized prostate cancer: a toxicity comparison
30. C2 STEREOTACTIC ABLATIVE RADIOTHERAPY (STAR) IN PATIENTS WITH ICD AND ARRHYTHMIC STORMS
31. PD-0575 Toxicity and QoL report of 1.5T MR-guided SBRT for prostate cancer in the first 100 patients
32. Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer (Front. Oncol., (2021), 11, (744956), 10.3389/fonc.2021.744956)
33. PSMA-guided SBRT for bone oligometastatic prostate cancer: a monoinstitutional report of preliminary outcomes and toxicity
34. Preliminary Dosimetric Analysis of the First 150 Sessions of 1.5-T MR-Guided Daily-Adaptive Radiotherapy for Abdomino-Pelvic Lymph-Nodal Oligometastases
35. Preliminary report of toxicity and quality of life of the first 100 patients treated with 1.5T MR-guided stereotactic body radiotherapy for prostate cancer
36. Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intra-fraction motion during 1.5 t-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancer
37. PO-1353 Postoperative hypofractionated RT for prostate adenocarcinoma: results from a large series
38. PO-1439 Clinical results of SBRT for spinal metastases using dedicated contouring/planning system
39. PO-1376 Preliminary mono-institutional report of prostate/prostate bed SBRT re-irradiation
40. PO-1499 1.5T MR-guided daily adaptive radiotherapy: preliminary clinical report of the first 2000 fractions.
41. PO-1388 1.5 T MR-guided SBRT for oligorecurrent prostate cancer: preliminary report of feasibility and PROMs
42. PD-0863 Preliminary dosimetric report of 1.5-T MR-guided daily-adaptive SBRT for lymph-nodal oligometastases
43. PO-1153 Preliminary mono-institutional report of stereotactic body radiotherapy for lung oligometastases
44. PO-1512 Daily adaptive MR-guided SBRT for oligometastatic lymph-nodes:feasibility and preliminary experience
45. 2003P Consolidative intrathoracic radiotherapy during maintenance first-line immunotherapy in extensive stage small cell lung cancer (ES-SCLC): A retrospective multicenter analysis of safety and efficacy
46. Resected atypical meningioma relapsed to anaplastic meningioma during luteinizing hormone-releasing hormone agonist therapy
47. PO-1540 1.5T MR-guided daily-adapted SBRT on lymphnode oligometastases from prostate cancer
48. PO-1530 Prostate SBRT on 1.5T MR-linac or linac-based VMAT: a comparison study from a prospective trial
49. PO-1134 Repeated SRS with linac-based monoisocentric technique in recurrent intracranial metastases
50. Linac-based SBRT for local recurrent prostate cancer after previous radiotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.